Clinical Trials Logo

Delivery of Health Care clinical trials

View clinical trials related to Delivery of Health Care.

Filter by:

NCT ID: NCT03715907 Completed - Clinical trials for Delivery of Health Care

Financial Incentives for Care Gaps

Start date: August 31, 2018
Phase: N/A
Study type: Interventional

This project seeks to understand how individuals respond to financial incentive programs for wellness care. In a randomized controlled trial among customers with care gaps, the investigators will experimentally compare the impacts of incentives for gap closure (gift cards), information on existing gaps (mailers), and no intervention. The research objectives are to assess how responsive individuals are to incentives for, and to information about, existing care gaps; and to assess spillovers from incentives onto other care. In addition, impacts on downstream utilization will be studied, which may be impacted if financial incentives are effective at increasing wellness visits.

NCT ID: NCT03459664 Completed - Clinical trials for Delivery of Health Care

Evaluation of a Cross-sectional Coordinated, Severity Stepped, Evidence-based Care Model for Mental Disorders

RECOVER
Start date: March 15, 2018
Phase: N/A
Study type: Interventional

This study evaluates a cross sectional, severity stepped, evidence-based care model for patients with mental disorders (RECOVER). RECOVER is a consortium of well-known institutions for the treatment and integrated care of patients with mental disorders, patient associations, relative associations, research institutions, health care insurances and authorities from the care region Hamburg, Germany. This project aims to evaluate the RECOVER care model with treatment as usual (TAU) regarding cost-effectiveness (costs, efficiency and cost utility) for patients with mental disorders. The following questions are examined: 1. Does RECOVER reduce psychiatric health care costs compared to TAU? 2. Does RECOVER improve patient relevant outcomes (i.e. symptom remission, response, daily functioning and quality of life)? 3. Is RECOVER cost effective compared to TAU? (from a payer's and societal perspective) A total sample of 890 patients with mental disorders will be assessed at baseline (before treatment) and randomized into the RECOVER care model or get TAU. Follow-up assessments are conducted after 6 month and 12 month. As primary outcomes, cost reduction, improvement in symptoms (i.e. amount of remission and response to treatment, daily functioning and quality of life) and cost-efficiency-ratios will be measured. In addition, several secondary outcome parameters will be assessed. Impact: The present randomized controlled trial (RCT) evaluates the cross-sectional, severity stepped, evidence-based approach of the RECOVER model in patients with mental disorders. With its focus on effectiveness and cost-effectiveness, the study aims to improve the health care system in Germany.

NCT ID: NCT03202745 Withdrawn - Clinical trials for Delivery of Health Care

The Effect of Informative Letters on the Prescription and Receipt of Opioids

Start date: January 2017
Phase: N/A
Study type: Interventional

Inappropriate prescribing exposes patients to health risks and results in wasteful public expenditures. This study will evaluate an approach to fighting abusive prescription: sending letters to suspected potentially inappropriate prescribers warning them that they are outliers compared to their peers and have been flagged for review. The study will target high prescribers of opioids in the Schedule II controlled substances class. Two types of letters will be tested: one focusing on the health consequences of inappropriate prescribing for patients, and the other focusing on the consequences for prescribers including e.g. potential administrative actions. Using claims data, the investigators will assess the effect of the letters on prescribing of opioids, receipt of opioids by patients, substitution behavior by prescribers and patients, and health outcomes of patients.

NCT ID: NCT02665429 Completed - Analgesics, Opioid Clinical Trials

A Quality Improvement Project to Investigate Individual Provider Variation in Opioid Prescribing From the Emergency Department

Start date: February 1, 2016
Phase: N/A
Study type: Interventional

This is a study of emergency physicians' prescribing patterns related to opioid (narcotic) medications. We are trying to determine whether giving providers access to their own prescribing data influences their prescribing patterns.

NCT ID: NCT02625142 Completed - Clinical trials for Delivery of Health Care

Family-Centered Rounds Checklist Implementation

Start date: February 2010
Phase: N/A
Study type: Interventional

The goal of this study is to develop, implement, and evaluate the effectiveness of an intervention designed to facilitate family engagement during bedside rounds at a children's hospital. The intervention consists of a "checklist" of key behaviors associated with the delivery of quality family-centered rounds, as well as training in the use of the checklist tool. In a pre-post controlled design, two hospital services will be randomized to use the checklist while two others will be randomized to usual care. The intervention is expected to increase to the performance of key checklist behaviors, family engagement, and family perceptions of patient safety.

NCT ID: NCT02467933 Completed - Clinical trials for Delivery of Health Care

The Effect of Informative Letters on the Prescription and Receipt of Seroquel

Start date: April 2015
Phase: N/A
Study type: Interventional

Abusive prescribing exposes patients to unnecessary health risks and results in wasteful public expenditures. This study will evaluate an innovative approach to fighting abusive prescription: sending letters to suspected inappropriate prescribers warning them that they are outliers compared to their peers and have been flagged for review. The study will target high prescribers of Seroquel (Quetiapine), an atypical antipsychotic. Using claims data, the investigators will assess the effect of the letters on prescribing of Seroquel, receipt of Seroquel by patients, substitution behavior by prescribers and patients, and health outcomes of patients.

NCT ID: NCT02345434 Completed - Clinical trials for Delivery of Health Care

The Effect of Informative Letters on the Prescription and Receipt of Schedule II Controlled Substances

Start date: August 2014
Phase: N/A
Study type: Interventional

Fraud and waste is estimated to cost the American health care system nearly $200 billion each year, and the public Medicare and Medicaid programs about $60 billion each year. This study will evaluate a new method for fighting fraud: mailing informative letters to outlier providers to notify them of their aberrant behavior. These letters are targeted at high prescribers of schedule II controlled substances in Medicare Part D. The investigators will look at the effects of these letters on the behavior of providers and their patients. These effects are of substantial policy interest as they suggest how to best design anti-fraud policies. They are also of academic interest, shedding light on the behavior of physicians and their patients.

NCT ID: NCT01304108 Completed - Clinical trials for Venous Thromboembolism

Improving Venous Thromboembolism Prophylaxis

Start date: January 2009
Phase: Phase 4
Study type: Interventional

Preventing the formation of blood clots in the veins so they do not injure leg veins or travel to the lungs, also called venous thromboembolism prophylaxis (VTE-P) is an essential component of safe in-patient care, yet it is deployed sub-optimally in many hospitals, including The investigators own. Two prior VTE-P improvement projects were completed at Mayo Clinic hospitals, one in the Department of Medicine, and the other in selected divisions of the Department of Surgery. Both projects resulted in marked improvement in the percentage of patients receiving appropriate VTE-P. This project seeks to utilize the lessons learned from these two pilots along with known best practices for "spreading" to deploy methods that enhance VTE-P to the entire hospitalized population. The investigators seek appropriate VTE-P rates exceeding 95%.

NCT ID: NCT01139398 Completed - Clinical trials for Delivery of Health Care

Effect of Limicol on (LDL)-Cholesterol Levels in Moderate Hypercholesterolaemia

Start date: May 2010
Phase: N/A
Study type: Interventional

The purpose of this study is to validate the effectiveness of food supplement Limicol on reducing LDL-cholesterol in moderate hypercholesterolemic volunteers.

NCT ID: NCT01137305 Completed - Clinical trials for Delivery of Health Care

Soft Skills and Surgical Performance

SSPSP
Start date: June 2008
Phase: N/A
Study type: Interventional

Background and hypothesis: Virtual reality (VR) training in minimal invasive surgery (MIS) is known to be feasible and beneficial in surgical residency. Research on stress- coping in surgical trainees indicate an additional impact of soft skills on VR- performance. Thus to hypothesize soft skills predicting surgical performance in a VR- setting. Method: A prospective randomized controlled single center educational trial was carried out to evaluate the impact of structured VR- training and defined soft skills such as self- efficacy, stress- coping and motivation on VR- performance.